Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
EMCURE.NSthis companyEmcure Pharmaceuticals Ltd.	₹2,216.20	32.72×	6.11×	3.29×	17.14×	-27.7%	38.9%	14.9%	10.0%	18.7%	15.0%	1.6%	0.31×	0.75×	9.56×	1.43×	0.2%	—	—	1	C-
ALKEM.NSAlkem Laboratories Limited	₹5,398.50	27.24×	4.54×	4.26×	18.9×	35.0%	65.4%	17.8%	15.6%	16.7%	12.5%	2.1%	0.15×	0.53×	16.32×	2.55×	1.0%	3	—	2	B-
AUROPHARMA.NSAurobindo Pharma Limited	₹1,855.30	21.62×	2×	2.25×	10.17×	130.3%	39.2%	15.1%	10.4%	9.2%	7.3%	3.7%	0.21×	-0.25×	13.22×	1.81×	0.3%	5	—	2	B-
CIPLA.NSCipla Limited	₹1,403.80	25.49×	2.87×	3.51×	15.19×	112.4%	42.7%	16.7%	13.8%	11.3%	9.8%	2.6%	0.02×	-0.06×	86.67×	3.44×	1.3%	4	9.92	4	A-
DRREDDY.NSDr. Reddy's Laboratories Limited	₹1,385.00	24.38×	2.77×	3.11×	14.13×	25.1%	52.8%	13.8%	12.8%	11.4%	7.5%	2.9%	0.24×	0.94×	12.42×	1.8×	0.6%	7	5.66	3	B+
GLENMARK.NSGlenmark Pharmaceuticals Limited	₹2,671.10	44.17×	5.72×	3.54×	21.53×	-44.3%	47.6%	23.5%	8.0%	13.0%	20.1%	3.2%	0.06×	-0.21×	19.16×	1.77×	0.2%	7	6.63	1	D+
Peer median	—	25.49×	2.87×	3.51×	15.19×	35.0%	47.6%	16.7%	12.8%	11.4%	9.8%	2.9%	0.15×	-0.06×	16.32×	1.81×	0.6%	5	6.63	2	—